Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15944866 | 1.00 | CA2 (0.39) | CA2CA1CA9CA7CA13 | |
| SCHEMBL14834076 | 0.84 | HTR1A (0.33) | CA2CA1 | |
| SCHEMBL6115024 | 0.79 | CA2 (0.41) | CA2CA1CA9CA7CA13 | |
| SCHEMBL1032931 | 0.79 | CA2 (0.47) | CA2CA1CA9CA7CA13 | |
| SCHEMBL116723 | 0.78 | CA2 (0.43) | CA2CA1CA9CA7CA13 | |
| SCHEMBL12487356 | 0.74 | CA2 (0.38) | CA2CA1CA9CA7CA13 | |
| SCHEMBL1855129 | 0.74 | CA2 (0.39) | CA2CA1CA9CA7CA13 | |
| SCHEMBL47322 | 0.74 | CA2 (0.43) | CA2CA1CA9CA7CA13 | |
| SCHEMBL12506990 | 0.74 | CA2 (0.39) | CA2CA1CA9CA7CA13 | |
| SCHEMBL18238737 | 0.74 | CA2 (0.38) | CA2CA1CA9CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096782-A1 | FLUORINATED CANNABINOID COMPOSITIONS AND METHODS THEREOF | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2025-05-08 | — | — | WO | claimed |
| EP-3538501-A1 | RADIOLABELING AGENTS, METHODS OF MAKING, AND METHODS OF USE THEREOF | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2019-09-18 | — | — | EP | claimed |
| WO-2018144101-A1 | RADIOLABELING AGENTS, METHODS OF MAKING, AND METHODS OF USE THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2018-08-09 | — | — | WO | claimed |
| WO-2025096782-A1 | FLUORINATED CANNABINOID COMPOSITIONS AND METHODS THEREOF | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2025-05-08 | — | — | WO | disclosed |
| WO-2025090723-A1 | HYDROFLUOROCARBON COMPOUNDS AND THEIR USE IN INTEGRATED CIRCUIT MANUFACTURING PROCESSES | VERSUM MATERIALS US, LLC (US) | 2025-05-01 | — | — | WO | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| US-11031626-B2 | Electrolytic solution and electrochemical device containing the same | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2021-06-08 | — | — | US | disclosed |
| US-20200099101-A1 | ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE CONTAINING THE SAME | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2020-03-26 | — | — | US | disclosed |
| EP-3621141-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-03-11 | — | — | EP | disclosed |
| US-20120177988-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120070731-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| US-20110015181-A1 | ALKYLAMINOPYRIDINE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2011-01-20 | — | — | US | disclosed |
| EP-2264026-A1 | ALKYLAMINOPYRIDINE DERIVATIVE | Banyu Pharmaceutical Co., Ltd. (JP) | 2010-12-22 | — | — | EP | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| US-7157600-B2 | Process for preparing (per) fluorohalogenethers | SOLVAY SOLEXIS S.P.A. (IT) | 2007-01-02 | — | — | US | disclosed |
| EP-1480739-A2 | APPARATUS FOR SYNTHESIS OF RADIOLABELED COMPOUNDS | Bioscan, Inc. (US) | 2004-12-01 | — | — | EP | disclosed |
| WO-2003064678-A2 | APPARATUS FOR SYNTHESIS OF RADIOLABELED COMPOUNDS | BIOSCAN, INC. (US) | 2003-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015181-A1 | ALKYLAMINOPYRIDINE DERIVATIVE | NPY4R, NPY1R, NPY2R | CA2 622/4885CA1 3676/4885CA9 2888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.